Skip to main navigation
logo
SAB Biotherapeutics Logo
  • ABOUT US
    Company Profile Executive Management Board of Directors Scientific Advisory Board
  • SAB-142
    SAB-142 Science Type 1 Diabetes (T1D) Expanded Access Policy
  • PARTNERING
  • Media
    News & Press Releases Events Presentations Publications
  • INVESTORS
    Overview SEC Filings Stock Quote & Chart Executive Management Board of Directors Board Committees Corporate Governance Scientific Advisory Board Analyst Coverage RSS Feeds Contact Us

Presentations

SAB Corporate Presentation
September 7, 2023
FOCIS 2023 Annual Meeting GLP Tox Poster Presentation - June 2023
June 22, 2023
THERAPEUTIC IMMUNOGLOBULIN (hIgG) FOR PRE- and POST EXPOSURE PROPHYLAXIS AND TREATMENT OF INFLUENZA BIO International Convention June 2023
June 8, 2023
Advancing a Powerful New Class of Therapeutic Immunoglobulins (hIgG): Sidoti Conference – May 2023
May 11, 2023
7th ISIRV-AVG Conference Presentation
May 4, 2023
Next Generation Biologics in Immunology: Solution for Complex Diseases
February 3, 2023
Next Generation Biologics in Immunology: Solution for Complex Diseases
January 20, 2023
CRI-ENCI-AACR Immunotherapy Conference Poster Presentation
December 6, 2022
12th International Plasma Product Biotechnology Conference Presentation
November 3, 2022
12th International Plasma Product Biotechnology Conference Presentation
November 3, 2022
Pagination
  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS
  • Investor FAQs
  • © SAB Biotherapeutics 2023

Footer Links

  • Terms & Conditions
  • Privacy Policy